CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

Under the new FDA guidelines, only people 65 and older and others with one or more health risk factors will be able to receive COVID-19 vaccinations. People considered healthy and under the age of 65 ...

Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.

A Phoenix doctor weighs in on the potential impact of FDA plans to limit COVID booster access to high-risk groups, raising ...

The Food and Drug Administration is implementing more rigorous standards for administering the COVID-19 vaccine and experts are worried.

The revised version of the vaccine, marketed as Spikevax, follows FDA guidance recommending that this year’s shots target ...

A new Covid variant, NB.1.8.1, is detected in US airports. The variant is driving a surge in cases across China. Cases are ...

The Food and Drug Administration (FDA) will require more evidence for what top officials describe as the uniquely American ...

MODERNA said on Friday it has filed a marketing application for the review of its updated Covid-19 vaccine with the US Food and Drug Administration (FDA).

Pfizer (NYSE: PFE) is a great example, with its shares down around 57% below the previous high. When a stock plunges as much ...

Earlier, Pakistan's Ambassador at the UN Asim Iftikhar Ahmad, in his remarks at the debate, raked the Kashmir issue and spoke about the recent conflict between India and Pakistan. Will Trump's ...